Sfoglia per Autore
KRAS mutational status and sensitivity to a reversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in EGFR wild type (WT) advanced non-small cell lung cancer (NSCLC) patients (pts)
2012 Metro, G; Duranti, S; Chiari, R; Bennati, C; Molica, C; Curra, Mf; Scafati, C; Siggillino, Annamaria; Flacco, A; Marcomigni, L; Ludovini, V; Minotti, V; Crino', Lucio
Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer Safety of Avastin in Lung trial (MO19390)
2012 Laskin, J; Crino', Lucio; Felip, E; Franke, F; Gorbunova, V; Groen, H; Jiang, Gl; Reck, M; Schneider, Cp
Results of A Global Phase Ii Study With Crizotinib In Advanced Alk-positive Non-small-cell Lung Cancer (NSCLC)
2012 Kim, Dw; Ahn, Mj; Shi, Y; De, Tm; Yang, Pc; Riel, y GJ; Crino', Lucio; Evans, Tl; Liu, X; Han, Jy; Salgia, R; Lanzalone, S; Poll, i A; Iyer, S; Shaw, At
Lack of Accuracy of Circulating Chromogranin A in the Preoperative Diagnosis of Lung Neuroendocrine Tumors
2012 Scarpelli, G; Daddi, Niccolo'; Maiettini, D; Pascucci, C; Minotti, V; Puma, Francesco; Crino', Lucio; Ferolla, Piero
Clinical characteristics of ALK plus NSCLC patients (pts) treated with crizotinib beyond disease progression (PD): Potential implications for management.
2012 Otterson, Ga; Riely, Gj; Shaw, At; Crino', Lucio; Kim, Dw; Martins, R; Salgia, R; Zhou, Cc; Solomon, Bj; Wilner, Kd; Polli, A; Tang, Yy; Bartlett, Ch; Ou, Shi
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study
2012 Faggiano, A; Ramundo, V; Dicitore, A; Castiglioni, S; Borghi, Mo; Severino, R; Ferolla, Piero; Crino', Lucio; Abbruzzese, A; Sperlongano, P; Caraglia, M; Ferone, D; Hofland, L; Colao, A; Vitale, G.
Impact of Kras Codon Sub-types In A Phase Ii Second-line Trial In Kras-mutant Advanced Non-small Cell Lung Cancer (nsclc) of Selumetinib Plus Docetaxel Versus Docetaxel Alone
2013 Liptrot, T; Mann, H; Smith, I; Mcwalter, G; Dougherty, B; Walker, J; Orr, Mc; Hodgson, D; Shaw, At; Pereira, Jr; Jeannin, G; Vansteenkiste, J; Barrios, Che; Franke, Fa; Crino', Lucio; Janne, Pa; Smith, P.
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
2013 Janne, P. A.; Shaw, A. T.; Pereira, J. R.; Jeannin, G; Vansteenkiste, J; Barrios, C; Franke, F. A.; Grinsted, L; Zazulina, V; Smith, P; Smith, I; Crino', Lucio
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
2013 Shaw, At; Kim, Dw; Nakagawa, K; Seto, T; Crino', Lucio; Ahn, Mj; Pas, Td; Besse, B; Solomon, Bj; Blackhall, F; Wu, Yl; Thomas, M; O'Byrne, Kj; Moro Sibilot, D; Camidge, Dr; Mok, T; Hirsh, V; Riely, Gj; Iyer, S; Tassell, V; Polli, A; Wilner, Kd; Janne, Pa
Coexistence of EGFR mutation and ALK translocation in NSCLC: Literature review and case report of response to gefitinib
2013 Santelmo, C; Ravaioli, A; Barzotti, E; Papi, M; Poggi, B; Drudi, F; Mangianti, M; Salvi, M; Crino', Lucio
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition
2013 Baldelli, E; Haura, Eb; Crino', Lucio; Cress, W. D; Ludovini, Vienna; Schabath, M. B; Bellezza, Guido; Vannucci, Jacopo; Tassi, V; Pistola, L; Tofanetti, Fr; Flacco, A; Siggillino, Annamaria; Liotta, La; Petricoin, Ef; Pierobon, M.
Prevalence of Pulmonary Embolism In Patients With Oncogene Addicted Advanced Lung Adenocarcinoma
2013 Crino', Lucio; Chiari, R; Verso, M; Bennati, C; Franco, L; Paglialunga, L; Fischer, M; Mosca, S; Marconi, V; Agnelli, Giancarlo
Recommendations for the Analysis of ALK Gene Rearrangements in Non-Small-Cell Lung Cancer A Consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology
2013 Marchetti, A; Ardizzoni, A; Papotti, M; Crino', Lucio; Rossi, G; Gridelli, C; Barberis, M; Maiorano, E; Normanno, N; Taddei, G. L.; Scagliotti, G; Clemente, C; Pinto, C.
Robustness of complex feedback systems: application to oncological biochemical networks
2013 Bianconi, Fortunato; Elisa, Baldelli; Vienna, Ludovini; Crino', Lucio; Katia, Perruccio; Valigi, Paolo
Afatinib In Egfr Mutant Non-small-cell Lung Cancer Patients With Acquired Resistance To Reversible Egfr-tkis
2013 Cappuzzo, F; Tiseo, M; Chiari, R; Landi, L; Ricciardi, S; Rossi, E; Galetta, D; Novello, S; Milella, M; D'Incecco, A; Haspinger, Er; Cortinovis, D; Santo, A; Banna, G; Facchi Netti, F; Levra, Mg; Vari, S; Crino', Lucio; Marinis, Fd
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC).
2013 Bellezza, Guido; DEL SORDO, Rachele; Colella, R; Ludovini, V; Ragusa, Mark; Bianconi, Fortunato; Ferri, I; Borri, F; Chiari, R; Puma, Francesco; Crino', Lucio; Sidoni, Angelo
RET rearrangements detected by FISH in "pan-negative" lung adenocarcinoma.
2013 Varella Garcia, M; Xu, L. G.; Mahale, S; Berge, E. M.; Bennati, C; Le, A. T.; Aisner, D; Crino', Lucio; Bunn, P. A.; Camidge, D. R.; Doebele, R. C.
Prevalence of Unexpected Pulmonary Embolism At Contrast-enhanced Ct Scan Performed For Cancer Staging In Patients With Advanced Lung Cancer
2013 Crino', Lucio; Chiari, R; Verso, M; Franco, L; Mosca, S; Fischer, M; Bennati, C; Marconi, V; Paglialunga, L; Agnelli, Giancarlo
Prognostic Impact of Cytoskeleton Regulatory Protein Human Mena (hmena) Isoforms In Resected, Node-negative, Non-smallcell Lung Cancer: Validation of A Clinic-molecular Prognostic Model
2013 Bria, E; Mottolese, M; Modugno, Fd; Alessandrini, G; Ludovini, V; Antoniani, B; Iapicca, B; Ceribelli, A; Sidoni, Angelo; Crino', Lucio; Cognetti, F; Facciolo, F; Visca, P; Pilotto, S; Tortora, G; Sperduti, I; Milella, M; Nistico, P.
Clinical Experience With Crizotinib In Patients With Advanced Alk-rearranged Non-small Cell Lung Cancer and Brain Metastases In Profile 1005 and Profile 1007
2013 Costa, Db; Shaw, At; Ou, Sh; Solomon, Bj; Riely, Gj; Ahn, Mj; Zhou, Cc; Shreeve, Sm; Wiltshire, R; Selaru, P; Polli, A; Schnell, P; Camidge, Dr; Crino', Lucio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| KRAS mutational status and sensitivity to a reversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in EGFR wild type (WT) advanced non-small cell lung cancer (NSCLC) patients (pts) | 2012 | Metro, G; Duranti, S; Chiari, R; Bennati, C; Molica, C; Curra, Mf; Scafati, C; Siggillino, Annamaria; Flacco, A; Marcomigni, L; Ludovini, V; Minotti, V; Crino', Lucio | |
| Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer Safety of Avastin in Lung trial (MO19390) | 2012 | Laskin, J; Crino', Lucio; Felip, E; Franke, F; Gorbunova, V; Groen, H; Jiang, Gl; Reck, M; Schneider, Cp | |
| Results of A Global Phase Ii Study With Crizotinib In Advanced Alk-positive Non-small-cell Lung Cancer (NSCLC) | 2012 | Kim, Dw; Ahn, Mj; Shi, Y; De, Tm; Yang, Pc; Riel, y GJ; Crino', Lucio; Evans, Tl; Liu, X; Han, Jy; Salgia, R; Lanzalone, S; Poll, i A; Iyer, S; Shaw, At | |
| Lack of Accuracy of Circulating Chromogranin A in the Preoperative Diagnosis of Lung Neuroendocrine Tumors | 2012 | Scarpelli, G; Daddi, Niccolo'; Maiettini, D; Pascucci, C; Minotti, V; Puma, Francesco; Crino', Lucio; Ferolla, Piero | |
| Clinical characteristics of ALK plus NSCLC patients (pts) treated with crizotinib beyond disease progression (PD): Potential implications for management. | 2012 | Otterson, Ga; Riely, Gj; Shaw, At; Crino', Lucio; Kim, Dw; Martins, R; Salgia, R; Zhou, Cc; Solomon, Bj; Wilner, Kd; Polli, A; Tang, Yy; Bartlett, Ch; Ou, Shi | |
| Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study | 2012 | Faggiano, A; Ramundo, V; Dicitore, A; Castiglioni, S; Borghi, Mo; Severino, R; Ferolla, Piero; Crino', Lucio; Abbruzzese, A; Sperlongano, P; Caraglia, M; Ferone, D; Hofland, L; Colao, A; Vitale, G. | |
| Impact of Kras Codon Sub-types In A Phase Ii Second-line Trial In Kras-mutant Advanced Non-small Cell Lung Cancer (nsclc) of Selumetinib Plus Docetaxel Versus Docetaxel Alone | 2013 | Liptrot, T; Mann, H; Smith, I; Mcwalter, G; Dougherty, B; Walker, J; Orr, Mc; Hodgson, D; Shaw, At; Pereira, Jr; Jeannin, G; Vansteenkiste, J; Barrios, Che; Franke, Fa; Crino', Lucio; Janne, Pa; Smith, P. | |
| Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study | 2013 | Janne, P. A.; Shaw, A. T.; Pereira, J. R.; Jeannin, G; Vansteenkiste, J; Barrios, C; Franke, F. A.; Grinsted, L; Zazulina, V; Smith, P; Smith, I; Crino', Lucio | |
| Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer | 2013 | Shaw, At; Kim, Dw; Nakagawa, K; Seto, T; Crino', Lucio; Ahn, Mj; Pas, Td; Besse, B; Solomon, Bj; Blackhall, F; Wu, Yl; Thomas, M; O'Byrne, Kj; Moro Sibilot, D; Camidge, Dr; Mok, T; Hirsh, V; Riely, Gj; Iyer, S; Tassell, V; Polli, A; Wilner, Kd; Janne, Pa | |
| Coexistence of EGFR mutation and ALK translocation in NSCLC: Literature review and case report of response to gefitinib | 2013 | Santelmo, C; Ravaioli, A; Barzotti, E; Papi, M; Poggi, B; Drudi, F; Mangianti, M; Salvi, M; Crino', Lucio | |
| Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition | 2013 | Baldelli, E; Haura, Eb; Crino', Lucio; Cress, W. D; Ludovini, Vienna; Schabath, M. B; Bellezza, Guido; Vannucci, Jacopo; Tassi, V; Pistola, L; Tofanetti, Fr; Flacco, A; Siggillino, Annamaria; Liotta, La; Petricoin, Ef; Pierobon, M. | |
| Prevalence of Pulmonary Embolism In Patients With Oncogene Addicted Advanced Lung Adenocarcinoma | 2013 | Crino', Lucio; Chiari, R; Verso, M; Bennati, C; Franco, L; Paglialunga, L; Fischer, M; Mosca, S; Marconi, V; Agnelli, Giancarlo | |
| Recommendations for the Analysis of ALK Gene Rearrangements in Non-Small-Cell Lung Cancer A Consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology | 2013 | Marchetti, A; Ardizzoni, A; Papotti, M; Crino', Lucio; Rossi, G; Gridelli, C; Barberis, M; Maiorano, E; Normanno, N; Taddei, G. L.; Scagliotti, G; Clemente, C; Pinto, C. | |
| Robustness of complex feedback systems: application to oncological biochemical networks | 2013 | Bianconi, Fortunato; Elisa, Baldelli; Vienna, Ludovini; Crino', Lucio; Katia, Perruccio; Valigi, Paolo | |
| Afatinib In Egfr Mutant Non-small-cell Lung Cancer Patients With Acquired Resistance To Reversible Egfr-tkis | 2013 | Cappuzzo, F; Tiseo, M; Chiari, R; Landi, L; Ricciardi, S; Rossi, E; Galetta, D; Novello, S; Milella, M; D'Incecco, A; Haspinger, Er; Cortinovis, D; Santo, A; Banna, G; Facchi Netti, F; Levra, Mg; Vari, S; Crino', Lucio; Marinis, Fd | |
| Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). | 2013 | Bellezza, Guido; DEL SORDO, Rachele; Colella, R; Ludovini, V; Ragusa, Mark; Bianconi, Fortunato; Ferri, I; Borri, F; Chiari, R; Puma, Francesco; Crino', Lucio; Sidoni, Angelo | |
| RET rearrangements detected by FISH in "pan-negative" lung adenocarcinoma. | 2013 | Varella Garcia, M; Xu, L. G.; Mahale, S; Berge, E. M.; Bennati, C; Le, A. T.; Aisner, D; Crino', Lucio; Bunn, P. A.; Camidge, D. R.; Doebele, R. C. | |
| Prevalence of Unexpected Pulmonary Embolism At Contrast-enhanced Ct Scan Performed For Cancer Staging In Patients With Advanced Lung Cancer | 2013 | Crino', Lucio; Chiari, R; Verso, M; Franco, L; Mosca, S; Fischer, M; Bennati, C; Marconi, V; Paglialunga, L; Agnelli, Giancarlo | |
| Prognostic Impact of Cytoskeleton Regulatory Protein Human Mena (hmena) Isoforms In Resected, Node-negative, Non-smallcell Lung Cancer: Validation of A Clinic-molecular Prognostic Model | 2013 | Bria, E; Mottolese, M; Modugno, Fd; Alessandrini, G; Ludovini, V; Antoniani, B; Iapicca, B; Ceribelli, A; Sidoni, Angelo; Crino', Lucio; Cognetti, F; Facciolo, F; Visca, P; Pilotto, S; Tortora, G; Sperduti, I; Milella, M; Nistico, P. | |
| Clinical Experience With Crizotinib In Patients With Advanced Alk-rearranged Non-small Cell Lung Cancer and Brain Metastases In Profile 1005 and Profile 1007 | 2013 | Costa, Db; Shaw, At; Ou, Sh; Solomon, Bj; Riely, Gj; Ahn, Mj; Zhou, Cc; Shreeve, Sm; Wiltshire, R; Selaru, P; Polli, A; Schnell, P; Camidge, Dr; Crino', Lucio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile